NCT05909631

Brief Summary

The goal of this clinical trial study is to investigate comparing Effects of Beetroot juice and Mediterranean diet on Liver Enzymes and Sonographic appearance in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) The main question\[s\] it aims to answer are:

  1. 1.Beetroot juice has role in reduce Liver Enzymes
  2. 2.Mediterranean diet has role in reduce Liver Enzymes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2023

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

1 month

First QC Date

May 10, 2023

Last Update Submit

June 8, 2023

Conditions

Keywords

Mediterranean dietBeetroot juicenonalcoholic fatty liver

Outcome Measures

Primary Outcomes (1)

  • Beetroot juice has role in reduce liver enzymes

    Beetroot juice was given for 12 weeks and has role in reduce Serum Bilirubin, alkaline phosphatase (ALP), alanine transaminase (ALT), and liver enzyme was measured by blood sampling tests.

    12 weeks

Secondary Outcomes (1)

  • Mediterranean diet contributes to lower liver enzyme levels.

    12 weeks

Study Arms (4)

250 ml of a placebo

PLACEBO COMPARATOR

250 ml of a placebo

Other: placebo

beetroot juice (BJ)

EXPERIMENTAL

250 ml of concentrated beetroot juice

Other: Beetroot juice

Mediterranean diet with beet juice (BJ+MeD)

EXPERIMENTAL

Mediterranean diet with beet juice (BJ+MeD)

Combination Product: Mediterranean diet with beet juice (BJ+MeD)

Mediterranean diet alone (MeD)

EXPERIMENTAL

Mediterranean diet alone (MeD)

Other: Mediterranean diet alone (MeD)

Interventions

250 ml of concentrated beetroot juice, were given to participants in the BJ groups .This was carried out in the morning, 30 minutes before breakfast, and on an empty stomach.

beetroot juice (BJ)
placeboOTHER

250 ml of a placebo

250 ml of a placebo

Mediterranean diet alone (MeD)

Mediterranean diet alone (MeD)

Mediterranean diet with beet juice (BJ+MeD).

Mediterranean diet with beet juice (BJ+MeD)

Eligibility Criteria

Age19 Years - 73 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients had to be between the ages of 19 and 73, and they had to have NAFLD as their main diagnosis.
  • For a NAFLD diagnosis, ultrasound proof of fatty liver (stage I or above) and an elevated level of liver enzymes were required.

You may not qualify if:

  • history of diseases like cardiovascular, liver, chronic hepatitis C, and kidney disease
  • supplement use within the previous six months; hormone therapy; use of drugs like amiodarone, methotrexate, and corticosteroids
  • cases of starvation or inadequate nutrition; pregnancy; metabolic disorders like Wilson disease and glycogen storage disease; a history of liver irradiation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hawal

Sulaymaniyah, Sulaimanyah, 46021, Iraq

Location

Related Publications (1)

  • Fateh HL, Rashid SA, Muhammad SS, Al-Jaf SH, Ali AM. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials. Front Nutr. 2023 Aug 17;10:1181706. doi: 10.3389/fnut.2023.1181706. eCollection 2023.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Hawal Lateef, Msc

    Nursing department, sulaimany polytechni university, kurdistan, iraq

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Statical analyser
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The participants were split into four groups: control, Mediterranean diet with beet juice (BJ+MeD), Mediterranean diet alone (MeD) and beetroot juice (BJ). The Mediterranean diet included fruits, vegetables, fish, poultry, and other lean meats (without skin), sources of omega-3 fatty acids, nuts, and legumes. Beetroot juice had 250 mg of beetroot.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Hawal Lateef Fateh

Study Record Dates

First Submitted

May 10, 2023

First Posted

June 18, 2023

Study Start

January 10, 2023

Primary Completion

February 20, 2023

Study Completion

April 11, 2023

Last Updated

June 18, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations